UPDATE 1-Mirum's liver infection drug lowers virus levels in second late-stage study

0

(Adds analyst comment in bullet 4) By Sahil Pandey Nov 10 (Reuters) – Mirum Pharmaceuticals said on Tuesday its experimental treatment for hepatitis delta, a serious liver infection, led to reduced

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)